Treatment of refractory adult acute nonlymphoblastic leukemia with subcutaneous 5-azacytidine.
D000328:Adult; D000368:Aged; D001374:Azacitidine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects; D002986:Clinical Trials as Topic; D004064:Digestive System / Q000187:drug effects; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007938:Leukemia / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D012867:Skin / Q000187:drug effects
D001374:Azacitidine